SCHEMBL25924747

SCHEMBL25924747

CCN1CCN(C2CC3(CCN(CC4CNC4)CC3)C2)CC1

nearest known ligand 0.39

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.35
KDM4E B2RXH2 1/20 0.30
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25027097 0.83 ACHE (0.39)
SCHEMBL25924749 0.79 TSHR (0.34) TSHR
SCHEMBL29317070 0.77 ACHE (0.35) TSHR
SCHEMBL24480587 0.73 GBA1 (0.32)
SCHEMBL24481348 0.72 TSHR (0.33) TSHRKDM4EGAA
SCHEMBL25924832 0.72 KDM4E (0.36) TSHRKDM4EGAA
SCHEMBL16203227 0.72 KMT2A (0.38) KDM4E
SCHEMBL25026748 0.72 TSHR (0.32) TSHR
SCHEMBL25026638 0.71
SCHEMBL25856125 0.71 TSHR (0.37) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023109892-A1 COMPOUND FOR INHIBITING OR DEGRADING BRD9, AND COMPOSITION AND PHARMACEUTICAL USE THEREOF 海思科医药集团股份有限公司 2023-06-22 WO disclosed